Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Eikelboom, Willem S.
van Rooij, Jeroen G. J.
van den Berg, Esther
Coesmans, Michiel
Jiskoot, Lize C.
Singleton, Ellen
Ossenkoppele, Rik
van Swieten, John C.
Seelaar, Harro
Papma, Janne M.
and
Lanctôt, Krista
2018.
Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer’s Disease: A Case Report.
Journal of Alzheimer's Disease,
Vol. 66,
Issue. 4,
p.
1363.
Cloutier, Martin
Gauthier‐Loiselle, Marjolaine
Gagnon‐Sanschagrin, Patrick
Guerin, Annie
Hartry, Ann
Baker, Ross A.
Duffy, Ruth
Gwin, Keva
and
Sanon Aigbogun, Myrlene
2019.
Institutionalization risk and costs associated with agitation in Alzheimer's disease.
Alzheimer's & Dementia: Translational Research & Clinical Interventions,
Vol. 5,
Issue. 1,
p.
851.
McDermott, Cara L.
and
Gruenewald, David A.
2019.
Pharmacologic Management of Agitation in Patients with Dementia.
Current Geriatrics Reports,
Vol. 8,
Issue. 1,
p.
1.
Ohno, Yukihiro
Kunisawa, Naofumi
and
Shimizu, Saki
2019.
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects.
Frontiers in Pharmacology,
Vol. 10,
Issue. ,
Keszycki, Rachel M.
Fisher, Daniel W.
and
Dong, Hongxin
2019.
The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions.
Frontiers in Pharmacology,
Vol. 10,
Issue. ,
Sajatovic, Martha
2019.
Commentary on “Caregiver-Care Recipient Relationship Closeness is Associated With Neuropsychiatric Symptoms in Dementia”.
The American Journal of Geriatric Psychiatry,
Vol. 27,
Issue. 4,
p.
360.
Jeste, Dilip V.
2019.
International Psychogeriatrics 2019: the year in review.
International Psychogeriatrics,
Vol. 31,
Issue. 12,
p.
1681.
Piau, Antoine
Rumeau, Pierre
Nourhashemi, Fati
and
Martin, Maria Soto
2019.
Information and Communication Technologies, a Promising Way to Support Pharmacotherapy for the Behavioral and Psychological Symptoms of Dementia.
Frontiers in Pharmacology,
Vol. 10,
Issue. ,
Bessey, Laurel J.
and
Walaszek, Art
2019.
Management of Behavioral and Psychological Symptoms of Dementia.
Current Psychiatry Reports,
Vol. 21,
Issue. 8,
Kales, Helen C.
Gitlin, Laura N.
and
Lyketsos, Constantine G.
2019.
When Less is More, but Still Not Enough: Why Focusing on Limiting Antipsychotics in People With Dementia Is the Wrong Policy Imperative.
Journal of the American Medical Directors Association,
Vol. 20,
Issue. 9,
p.
1074.
Eikelboom, Willem S.
Singleton, Ellen
van den Berg, Esther
Coesmans, Michiel
Mattace Raso, Francesco
van Bruchem, Rozemarijn L.
Goudzwaard, Jeannette A.
de Jong, Frank Jan
Koopmanschap, Marc
den Heijer, Tom
Driesen, Jan J. M.
Vroegindeweij, Lilian J. H. M.
Thomeer, Elsbeth C.
Hoogers, Susanne E.
Dijkstra, Anke A.
Zuidema, Sytse U.
Pijnenburg, Yolande A. L.
Scheltens, Philip
van Swieten, John C.
Ossenkoppele, Rik
and
Papma, Janne M.
2019.
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer’s disease: protocol of the BEAT-IT study.
Alzheimer's Research & Therapy,
Vol. 11,
Issue. 1,
Aerts, Liesbeth
Cations, Monica
Harrison, Fleur
Jessop, Tiffany
Shell, Allan
Chenoweth, Lynn
and
Brodaty, Henry
2019.
Why deprescribing antipsychotics in older people with dementia in long‐term care is not always successful: Insights from the HALT study.
International Journal of Geriatric Psychiatry,
Vol. 34,
Issue. 11,
p.
1572.
Ferguson, Claire
Shade, Marcia Y.
Blaskewicz Boron, Julie
Lyden, Elizabeth
and
Manley, Natalie A.
2020.
Virtual Reality for Therapeutic Recreation in Dementia Hospice Care: A Feasibility Study.
American Journal of Hospice and Palliative Medicine®,
Vol. 37,
Issue. 10,
p.
809.
Caraci, Filippo
Santagati, Mario
Caruso, Giuseppe
Cannavò, Dario
Leggio, Gian Marco
Salomone, Salvatore
and
Drago, Filippo
2020.
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin.
F1000Research,
Vol. 9,
Issue. ,
p.
686.
Srinivasan, Shilpa
Tampi, Rajesh R
Balaram, Kripa
and
Kapoor, Arushi
2020.
Pimavanserin for the treatment of psychosis in Alzheimer’s disease: A literature review.
World Journal of Psychiatry,
Vol. 10,
Issue. 7,
p.
162.
Aigbogun, Myrlene Sanon
Cloutier, Martin
Gauthier-Loiselle, Marjolaine
Guerin, Annie
Ladouceur, Martin
Baker, Ross A.
Grundman, Michael
Duffy, Ruth A.
Hartry, Ann
Gwin, Keva
Fillit, Howard
and
Jensen-Dahm, Christina
2020.
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review.
Journal of Alzheimer's Disease,
Vol. 77,
Issue. 3,
p.
1181.
Möllers, Tobias
Perna, Laura
Stocker, Hannah
Ihle, Peter
Schubert, Ingrid
Schöttker, Ben
Frölich, Lutz
and
Brenner, Hermann
2020.
New use of psychotropic medication after hospitalization among people with dementia.
International Journal of Geriatric Psychiatry,
Vol. 35,
Issue. 6,
p.
640.
Ballard, Clive
Kales, Helen C.
Lyketsos, Constantine
Aarsland, Dag
Creese, Byron
Mills, Roger
Williams, Hilde
and
Sweet, Robert A.
2020.
Psychosis in Alzheimer’s Disease.
Current Neurology and Neuroscience Reports,
Vol. 20,
Issue. 12,
Beaver, J.
Goldberg, S.E.
Edgley, A.
and
Harwood, R.H.
2020.
‘Socialised care futility’ in the care of older people in hospital who call out repetitively: An ethnographic study.
International Journal of Nursing Studies,
Vol. 107,
Issue. ,
p.
103589.
Scuteri, Damiana
Matamala-Gomez, Marta
Bottiroli, Sara
Corasaniti, Maria Tiziana
De Icco, Roberto
Bagetta, Giacinto
and
Tonin, Paolo
2020.
Pain Assessment and Treatment in Dementia at the Time of Coronavirus Disease COVID-19.
Frontiers in Neurology,
Vol. 11,
Issue. ,